RX Cap for Lung Cancer
This trial will test a remote monitoring system for patients on TKI therapy for lung cancer, including a smartphone app, fitness watch, and smart pill cap.
- Lung Cancer
- Epidermal Growth Factor Receptor Mutations
- Epidermal Growth Factor Receptor (EGFR)
- Gene Mutation
- BRAF Mutation
- ROS1 Gene Mutation
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there limits to the number of volunteers in this research endeavor?
"Yes, the information available on clinicaltrials.gov reveals that this medical research is currently looking for participants; it was first posted 25th August 2022 and updated 26th August 2022. The trial requires 75 people to be enrolled from one medical site."
Is enrollment still available for this clinical exploration?
"Clinicialtrials.gov reports that this medical trial is currently recruiting participants, and the study was originally posted on August 25th 2022 with its most recent revision taking place a day later."